Clinical Trials
12 trialsNCT03579446 2025-08-03
Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Terminated
NCT05017246 2025-07-31
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
Washington University School of Medicine
Phase 2 Terminated
NCT01318161 2021-02-16
EPICOL
Örebro University, Sweden
Phase 3 Terminated
NCT02659501 2021-01-12
Liposomal Bupivacaine in Implant Based Breast Reconstruction
Loma Linda University
Phase NA Terminated
NCT00726830 2020-09-24
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
M.D. Anderson Cancer Center
Phase NA Terminated
NCT02591017 2018-11-13
ONKEMI
University Hospital, Basel, Switzerland
Phase 3 Terminated
NCT02044302 2017-04-10
A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction
Yale University
Phase 2 Terminated
NCT02078089 2017-01-31
Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain
Indiana University
Phase 1 Terminated
NCT00634010 2016-05-09
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00558870 2016-04-05
Role of Methadone As Co-Opioid Analgesic
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00573937 2016-02-19
Methadone Versus Morphine for Cancer-Related Pain
Mayo Clinic
Phase 2 Terminated
NCT00660348 2014-10-08
Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Terminated